Quercetin induces cell cycle G1 arrest through elevating Cdk inhibitors p21 and p27 in human hepatoma cell line (HepG2)

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 29, Issue 3, 2007, Pages 179-183

  Mu, C ^a   Jia, P ^a   Yan, Z ^a   Liu, X ^a   Li, X ^a   Liu, Heng ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

HepG2; p21; p27; p53; Quercetin

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 1B; QUERCETIN;

ARTICLE; CELL CYCLE ARREST; CELL PROLIFERATION; CELL STRAIN HEPG2; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG INHIBITION; DRUG STRUCTURE; HUMAN; HUMAN CELL;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; G1 PHASE; HUMANS; QUERCETIN;

EID: 34250338494     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2007.29.3.1092095     Document Type: Article

References (46)

1. Bruix, J., Sherman, M., Llovet, J.M. et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001, 35(3): 421-30.
2. Block, G., Patterson, B., Subar, A. Fruit, vegetables, and cancer prevention: A review of the epidemiological evidence. Nutr Cancer 1992, 18: 1-29.
3. Eberhardt, M.V., Lee, C.Y., Liu, R.H. Antioxidant activity of fresh apples. Nature 2000, 405: 903-4.
4. Wolfe, K.L., Liu, R.H. Apple peels as a value-added food ingredient. J Agric Food Chem 2003, 51:1676-83.
5. Kuo, S.M., Leavit, P.S., Lin, C.P. Dietary flavonoids interact with trace metals and affect metallothionein level in human intestinal cells. Biol Trace Elem Res 1998, 62: 135-53.
6. Scambia, G., Ranellelti, F.O., Benedelti, P.P. et al. Type-II estrogen binding sites in a lymphoblastoid cell line and growth-inhibitory effect of estrogen, anti-estrogen and bioflavonoids. Int J Cancer 1990, 46: 1112-6.
7. Markaverich, B.M., Roberts, R.R., Alejandro, M.A., Johnson, G.A., Middledilch, B.S., Clark, J.H. Bioflavonoid interaction with rat uterine type II binding sites and cell growth inhibition. J Steroid Biochem 1988, 30: 71-8.
8. Larocca, L.M., Piantelli, M., Leone, G. et al. Type II oestrogen binding sites in acute lymphoid and myeloid leukaemias: Growth inhibitory effect of oestrogen and flavonoids. Br J Haematol 1990. 75: 489-95.
9. Hosokawa, N., Hosokawa, Y., Sakai, T. et al. Inhibitory- effect of quercetin on the synthesis of a possibly cell-cycle-rehtted 17-kDa protein, in human colon cancer cells. Int J Cancer 1990, 45: 1119-24.
10. Kuo, M.L., Lin, J.K., Huang, T.S., Yang, N.C. Reversion of the transformed phenotypes of v-H-ras NIH3T3 cells by flavonoids through attenuating the content of phosphotyrosine. Cancer Lett 1994, 87:91-7.
11. Larocca, L.M., Giustacchini, M., Maggiano, N. et al. Growth-inhibitory effect of quercetin and presence of type II estrogen binding sites in primary human transitional cell carcinomas. J Urol 1994, 152: 1029-33.
12. Yoshida, M., Yamamoto, M., Nikaido, T. Quercetin arrests human leukemic T-cells in late G1 phase of the cell cycle. Cancer Res 1992, 52:6676-81.
13. Avila, M.A., Velasco, J.A., Cansado, J., Notario, V. Quercetin mediates the down regulation of mutant p53 in the human breast cancer cell line MDA-MB468. Cancer Res 1994, 54: 2424-8.
14. Plaumann, B., Fritsche, M., Rimpler, H., Brandner, G., Hess, R.D. Flavonoids activate wild-type p53. Oncogene 1996, 13: 1605-14.
15. Ferrandina, G., Almadori, G., Maggiano, N. et al. Growth-inhibitory effect of tamoxifen and quercetin and presence of type II estrogen binding sites in human laryngeal cancer cell lines and primary laryngeal tumors. Int J Cancer 1998, 77: 747-54.
16. Agullo, G., Gamet-Payrastre, L., Manenti, S. et al. Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: A comparison with tyrosine kinase and protein kinase C inhibition. Biochem Pharmacol 1997, 53: 1649-57.
17. Hagiwara, M., Inoue, S., Tanaka, T., Nunoki, K., Ito, M., Hidaka, H. Differential effects of flavonoids as inhibitors of tyrosine protein kinases and serine/threonine protein kinases. Biochem Pharmacol 1988, 37: 2987-92.
18. Huang, Y.T., Hwang, J.J., Lee, P.P. et al. Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A43I cells over expressing epidermal growth factor receptor. Br J Pharmacol 1999, 128: 999-1010.
19. Aligiannis, N., Mitaku, S., Mitrocotsa, D., Leclerc, S. Flavonoids as cycline dependent kinase inhibitors: Inhibition of cdk 25 phosphatase activity by flavonoids belonging to the quercetin and kaempferol series. Planta Med 2001, 67: 468-70.
20. Gamet-Payrastre, L., Manenti, S., Gratacap, M.P., Tulliez, J., Chap, H., Payrastre, B. Flavonoids and the inhibition of PKC and PI 3-kinase. Gen Pharmacol 1999, 32: 279-86.
21. Shibasaki, F., Fukui, Y., Takenawa, T. Different properties of monomer and heterodimer forms of phosphatidylinositol 3-kinases. Biochem J 1993, 289: 227-31.
22. Constantinou, A., Mehta, R., Runyan, C., Rao, K., Vaughan, A., Moon, R. Flavonoids as DNA topoisomerase antagonists and poisons: Structure-activity relationships. J Natl Prod 1995, 58: 217-25.
23. Lee, S.C., Kuan, C.Y., Yang, C.C., Yang, S.D. Bioflavonoids commonly and potently induce tyrosine dephosphorylationl inactivation of oncogenic proline-directed protein kinase FA in human prostate carcinoma cells. Anticancer Res 1998, 18: 1117-21.
24. Suolinna, E.M., Lang, D.R., Racker, E. Quercetin, an artificial regulator of the high aerobic glycolysis of tumor cells. J Natl Cancer Inst 1974, 53: 1515-9.
25. Yoshizumi, M., Tsuchiya, K., Kirima, K., Kyaw, M., Suzaki, Y., Tamaki, T. Quercetin inhibits She- and phosphatidylinositol 3-kinase-mediated c-Jun N-terminal kinase activation by angiotensin II in cultured rat aortic smooth muscle cells. Mol Pharmacol 2001, 60: 656-65.
26. Moskaug, J.O., Carlsen, H., Myhrstad, M., Blomhoff, R. Molecular imaging of the biological effects of quercetin and quercetin-rich foods. Mech Ageing Dev 2004, 125: 315-24.
27. Xing, N.Z., Chen, Y., Mitchell, S.H., Young, C.Y.F. Quercetin inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells. Carcinogenesis 2001, 22: 409-14.
28. Takashi, N., Munehisa, U., Masahiro, I., Risa, H., Nobuhiro, D. Effects of quercetin on the heat-induced cytotoxicity of prostate cancer cells. Int J Urol 2001, 8: 623-30.
29. Wei, Y.Q., Zhao, X., Kariya, Y., Fukata, H., Teshigawara, K., Uchida, A. Induction of apoptosis by quercetin: Involvement of heat shock protein. Cancer Res 1994, 54: 4952-7.
30. Aprelikova, O., Xiong, Y., Liu, E.T. Both p16 and p21 families of cyclin-dependent kinase (Cdk) inhibitors block the phosphorylation of cyclin-dependent kinases by the cdk-activating kinase. J Biol Chem 1995, 270: 18195-7.
31. Kwon, T.K., Nagel, J.E., Buchholz, M.A., Nordin, A.A. Characterisation of the murine cyclin-dependent kinase inhibitor gene p27Kip1. Gene 1996, 180: 113-20.
32. El-Deiry, W.S. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 1994, 54: 1169-74.
33. Noda, A., Ning, Y., Venable, S.F., Pereira-Smith, O.M., Smith, J.R. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 1994, 211: 90-8.
34. Linda, J.K., Carol, P. p53: Puzzle and paradime. Genes Dev 1996, 10: 1054-72.
35. Parker, S.B., Eichele, G., Zhang, P. et al. p53-independent expression of p21cip1 in muscle and other terminally differentiating cells. Science 1995, 267: 1024-7.
36. Liang, Y.C., Lin-Shiau, S.Y., Chen, C.F., Lin, J.K. Inhibition of cyclin-dependent kinase 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate. J Cell Biochem 1998, 75: 1-12.
37. Lamson, D.W., Brignall, M.S. Antioxidants and cancer. III. Quercetin. Altern Med Rev 2000, 5: 196-208.
38. Pan, M.H., Chen, W.J., Lin-Shiau, S.Y., Ho, C.T., Lin, J.K. Tangeretin induces cell cycle G1 arrest through inhibiting cyclin-dependent kinases 2 and 4 activities as well as elevating Cdk inhibitors p21 and p27 in human colorectal carcinoma cells. Carcinogenesis 2002, 23: 1677-84.
39. Ramos, S., Aliaa, M., Bravo, L., Goya, L. Comparative effects of food-derived polyphenols on the viability and apoptosis of a human hepatoma cell line (HepG2). J Agric Food Chem 2005, 53: 1271-80.
40. Gugler, R., Leschik, M., Dengler, H.J. Disposition of quercetin in man after single oral and intravenous doses. Eur J Clin Pharmacol 1975, 9:229-34.
41. Yoshida, M., Sakai, T., Hosokawa, N. et al. The effect of quercetin on cell cycle progression and growth of human gastric cancer cells. FEBS Lett 1990, 260: 10-3.
42. Bates, S., Vousden, K.H. p53 in signaling checkpoint arrest and apoptosis. Curr Opin Genet Dev 1996, 6: 1-7.
43. Levine, A.J. p53, the cellular gatekeeper for growth and division. Cell 1997, 88: 323-31.
44. Waldman, T., Kinzler, K.W., Vogelstein, B. p21 is necessary for the p53-mediated G1 arrest in human cancer celt. Cancer Res 1995, 55: 5187-90.
45. Sherr, C.J. Cancer cell cycles. Science 1996, 274: 1672-7.
46. Fero, M.L., Rivkin, M., Tasch, M. et al. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis and female sterility in p27 (Kip1)-deficient mice. Cell 1996, 85: 733-44.